Johnson & Johnson Portfolio Stock Holdings
Johnson & Johnson disclosed 16 stock positions valued at approximately $652.4 million in its latest SEC 13F filing. The largest holdings include Protagonist Therapeutics Inc., Nanobiotix S.A., and Rapport Therapeutics, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 13, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 16
- Portfolio Value
- $652.4M
Holdings by Sector
Johnson & Johnson Portfolio Holdings in Q1 2026
11 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics Inc. | PTGX | Healthcare | 39.57% | 2,449,183 | - | - | $258,143,888 |
| Nanobiotix S.A. | NBTX | Healthcare | 26.61% | 5,623,816 | - | - | $173,607,200 |
| Rapport Therapeutics, Inc. | RAPP | Healthcare | 8.56% | 1,784,517 | - | - | $55,837,537 |
| CVRx, Inc. | CVRX | Healthcare | 5.84% | 4,024,861 | - | - | $38,075,185 |
| Contineum Therapeutics Inc. | CTNM | Healthcare | 3.96% | 1,979,173 | - | - | $25,847,999 |
| Legend Biotech Corporation | LEGN | Healthcare | 2.26% | 814,586 | - | - | $14,735,861 |
| Xencor, Inc. | XNCR | Healthcare | 1.38% | 748,062 | - | - | $9,021,628 |
| Procept BioRobotics Corporation | PRCT | Healthcare | 1.37% | 357,939 | - | - | $8,952,054 |
| Fate Therapeutics, Inc. | FATE | Healthcare | 0.62% | 3,379,064 | - | - | $4,054,877 |
| Neumora Therapeutics, Inc. | NMRA | Healthcare | 0.55% | 1,849,445 | - | - | $3,606,418 |
| Standard BioTools, Inc. | LAB | Healthcare | 0.04% | 311,967 | - | - | $286,791 |